Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

Avidity Biosciences, Inc. (RNA)

26.41
+0.15
+(0.57%)
As of 1:47:29 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
10.90M
10.90M
9.56M
9.22M
9.33M
Operating Expense
389.83M
389.83M
245.16M
188.14M
127.38M
Operating Income
-378.94M
-378.94M
-235.60M
-178.91M
-118.05M
Net Non Operating Interest Income Expense
56.88M
56.88M
23.97M
4.97M
104.00k
Other Income Expense
-248.00k
-248.00k
-594.00k
-57.00k
-62.00k
Pretax Income
-322.30M
-322.30M
-212.22M
-174.00M
-118.01M
Net Income Common Stockholders
-322.30M
-322.30M
-212.22M
-174.00M
-118.01M
Diluted NI Available to Com Stockholders
-322.30M
-322.30M
-212.22M
-174.00M
-118.01M
Basic EPS
-2.89
--
-2.91
-3.34
-5.70
Diluted EPS
-2.89
--
-2.91
-3.34
-5.70
Basic Average Shares
111.58M
--
73.01M
52.16M
20.71M
Diluted Average Shares
111.58M
--
73.01M
52.16M
20.71M
Total Operating Income as Reported
-378.94M
-378.94M
-235.60M
-178.91M
-118.05M
Total Expenses
389.83M
389.83M
245.16M
188.14M
127.38M
Net Income from Continuing & Discontinued Operation
-322.30M
-322.30M
-212.22M
-174.00M
-118.01M
Normalized Income
-322.30M
-322.30M
-212.22M
-174.00M
-118.01M
Interest Income
56.88M
56.88M
23.97M
4.97M
104.00k
Interest Expense
--
--
--
0.00
0.00
Net Interest Income
56.88M
56.88M
23.97M
4.97M
104.00k
EBIT
-378.94M
-378.94M
-235.60M
-178.91M
-118.05M
EBITDA
-376.16M
-376.16M
-233.50M
-177.53M
-117.41M
Reconciled Depreciation
2.78M
2.78M
2.10M
1.39M
639.00k
Net Income from Continuing Operation Net Minority Interest
-322.30M
-322.30M
-212.22M
-174.00M
-118.01M
Normalized EBITDA
-376.16M
-376.16M
-233.50M
-177.53M
-117.41M
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
0.00
0.00
0.00
0.00
0.00
12/31/2021 - 6/12/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACLX Arcellx, Inc.
53.78
+1.86%
 
DYN Dyne Therapeutics, Inc.
9.41
-6.09%
 
PCVX Vaxcyte, Inc.
29.25
+0.03%
 
KRYS Krystal Biotech, Inc.
135.78
-2.65%
 
CYTK Cytokinetics, Incorporated
33.95
-0.06%
 
PTCT PTC Therapeutics, Inc.
40.58
+12.13%
 
AKRO Akero Therapeutics, Inc.
42.57
+1.31%
 
MRUS Merus N.V.
39.97
+1.33%
 
CRNX Crinetics Pharmaceuticals, Inc.
31.57
+3.44%
 
BBIO BridgeBio Pharma, Inc.
35.81
-3.07%